Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
Alpar HO, Somavarapu S, Atuah KN, Bramwell VW. Alpar HO, et al. Adv Drug Deliv Rev. 2005 Jan 10;57(3):411-30. doi: 10.1016/j.addr.2004.09.004. Adv Drug Deliv Rev. 2005. PMID: 15560949 Review.
Adjuvant synergy: the effects of nasal coadministration of adjuvants.
Moschos SA, Bramwell VW, Somavarapu S, Alpar HO. Moschos SA, et al. Immunol Cell Biol. 2004 Dec;82(6):628-37. doi: 10.1111/j.0818-9641.2004.01280.x. Immunol Cell Biol. 2004. PMID: 15550121
Oral plasmid DNA delivery systems for genetic immunisation.
Somavarapu S, Bramwell VW, Alpar HO. Somavarapu S, et al. J Drug Target. 2003;11(8-10):547-53. doi: 10.1080/10611860410001683022. J Drug Target. 2003. PMID: 15203924
Intranasal vaccination against plague, tetanus and diphtheria.
Alpar HO, Eyles JE, Williamson ED, Somavarapu S. Alpar HO, et al. Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):173-201. doi: 10.1016/s0169-409x(01)00166-1. Adv Drug Deliv Rev. 2001. PMID: 11516788 Review.
Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids.
Bramwell VW, Somavarapu S, Outschoorn I, Alpar HO. Bramwell VW, et al. J Drug Target. 2003;11(8-10):525-30. doi: 10.1080/10611860410001670080. J Drug Target. 2003. PMID: 15203921
., Williamson, E.D. and Somavarapu, S. (2001) "Intranasal vaccination against plague, tetanus and diphtheria", Adv. Drug Delivery Rev. 51, 173-201] we hypothesized that melittin may have potential as a mucosal adjuvant. ...
., Williamson, E.D. and Somavarapu, S. (2001) "Intranasal vaccination against plague, tetanus and diphtheria", Adv. Drug Deliv …
Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S. Sayin B, et al. Int J Pharm. 2008 Nov 3;363(1-2):139-48. doi: 10.1016/j.ijpharm.2008.06.029. Epub 2008 Jul 9. Int J Pharm. 2008. PMID: 18662762
Effect of vitamin E TPGS on immune response to nasally delivered diphtheria toxoid loaded poly(caprolactone) microparticles.
Somavarapu S, Pandit S, Gradassi G, Bandera M, Ravichandran E, Alpar OH. Somavarapu S, et al. Int J Pharm. 2005 Jul 25;298(2):344-7. doi: 10.1016/j.ijpharm.2005.03.029. Int J Pharm. 2005. PMID: 15967606
Immobilisation of vaccines onto micro-crystals for enhanced thermal stability.
Murdan S, Somavarapu S, Ross AC, Alpar HO, Parker MC. Murdan S, et al. Int J Pharm. 2005 May 30;296(1-2):117-21. doi: 10.1016/j.ijpharm.2005.02.022. Epub 2005 Apr 11. Int J Pharm. 2005. PMID: 15885463
Development of Novel Octanoyl Chitosan Nanoparticles for Improved Rifampicin Pulmonary Delivery: Optimization by Factorial Design.
Petkar KC, Chavhan S, Kunda N, Saleem I, Somavarapu S, Taylor KMG, Sawant KK. Petkar KC, et al. Among authors: somavarapu s. AAPS PharmSciTech. 2018 May;19(4):1758-1772. doi: 10.1208/s12249-018-0972-9. Epub 2018 Mar 27. AAPS PharmSciTech. 2018. PMID: 29589222
62 results
Jump to page
Feedback